Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Genomic Health Inc. Stories

2013-07-24 08:30:11

REDWOOD CITY, Calif., July 24, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, July 31 at 4:30 p.m. Eastern Time to discuss its second quarter 2013 financial results. The call and webcast will follow the release of the second quarter financial results after market close. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Conference Call DetailsTo access the live...

2013-05-31 08:24:39

Prognostic Information from Oncotype DX in Metastatic Breast Cancer Indicates Importance of Biology Revealed by the Test Across Continuum of the Disease REDWOOD CITY, Calif., May 31, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of 10 studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, underscoring the company's commitment to optimizing cancer treatment. New data include studies of the Oncotype DX®...

2013-05-28 16:26:21

REDWOOD CITY, Calif., May 28, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in June: Jefferies 2013 Global Healthcare Conference on Monday, June 3 at 4:30 p.m. Eastern Time (ET) in New York City; and Goldman Sachs 34th Annual Global Healthcare Conference on Tuesday, June 11 at 2:00 p.m. Pacific Time (PT) in Rancho Palos Verdes, California. (Logo:...

2013-05-21 08:29:13

REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from ten studies in breast, colon and prostate cancer, including a large next generation sequencing (NGS) study, will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 - June 4, 2013 at McCormick Place in Chicago. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Presentations include: Results from...

2013-05-16 12:29:49

CHICAGO, May 16, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Genomic Health Inc. (Nasdaq:GHDX), Sanofi (NYSE:SNY), Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN), Amgen Inc. (Nasdaq:AMGN) and Isis Pharmaceuticals, Inc. (Nasdaq:ISIS). (Logo:...

2013-05-10 16:24:42

REDWOOD CITY, Calif., May 10, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that, effective May 8, 2013, Palmetto GBA, the designated national contractor for its Oncotype DX® breast cancer test, has expanded its coverage policy for all qualified Medicare patients to include patients with ductal carcinoma in situ (DCIS) following the recent publication of the breast cancer test's DCIS Score in the peer-reviewed, Journal of the National Cancer Institute....

2013-05-08 00:21:56

Groundbreaking Results from University of California, San Francisco (UCSF) Clinical Validation Study Presented at American Urological Association (AUA) Annual Meeting SAN DIEGO, May 8, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) is making its Oncotype DX® prostate cancer test available to physicians and their patients today following the presentation by the University of California, San Francisco (UCSF) of a positive clinical validation study at the 2013 American...

2013-05-07 16:29:38

REDWOOD CITY, Calif., May 7, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the 2013 Bank of America Merrill Lynch Health Care Conference in Las Vegas on Tuesday, May 14 at 5:00 p.m. Pacific Time (PT). (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's website at...

2013-05-02 16:30:17

Findings Demonstrate Utility of Oncotype DX® to Guide Radiation Treatment Decision for DCIS Patients and Support Expanded Access and Reimbursement REDWOOD CITY, Calif. and PHILADELPHIA, May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) and the ECOG-ACRIN Cancer Research Group announced today that the Journal of the National Cancer Institute (JNCI) published positive results from their clinical validation study of the Oncotype DX® DCIS Score in patients with...

2013-05-02 16:28:53

Product Revenue Increased 8% Compared to Prior Year REDWOOD CITY, Calif., May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Total revenue for the first quarter of 2013 increased to $63.1 million, compared with $58.5 million in the first quarter of 2012. Product revenue was $62.7 million in the first...